Pharmafile Logo
Pharmafocus logo
Advanced Search

New Sanofi/Alphabet partnership names CEO

September 12, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, appointment, google

As part of the news that French drugmaker Sanofi and Google parent Alphabet’s life sciences firm Verily are to join …

Appointment
als_ely_facility

ALS Pharma quadruples Cambridgeshire testing facility in £2m expansion

September 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing ALS Pharmaceutical, Microbiology, expansion

UK microbiology and chemical analysis company ALS Pharmaceutical has quadrupled the size of its facility in Ely, Cambridgeshire as part …

News

Bayer ponders $1.1 billion portfolio sale to fund Monsanto acquisition

September 12, 2016
Business Services, Manufacturing and Production, Sales and Marketing Bayer, acquisition, monsanto

In the latest development in the Bayer-Monsanto saga, the German drugmaker has enlisted the aid of global financial services firm …

News

GSK sells anaesthetic portfolio to Aspen for up to $372 million

September 12, 2016
Sales and Marketing

GlaxoSmithKline is to sell its portfolio of anaesthetic drugs to South African firm Aspen Pharmacare in a deal worth up …

News
ianreadweb

Clinton plan “negative for innovation”, says Pfizer CEO

September 12, 2016
Sales and Marketing Hilary Clinton

Democrat presidential candidate Hilary Clinton’s plan to tackle “unjustified price hikes” outlined last week is “very negative for innovation”, according …

News
google

Sanofi and Google forge $500 million diabetes partnership

September 12, 2016
Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, diabetes, google

Sanofi is set to join forces with Alphabet’s life sciences firm Verily in a $500 million partnership to develop diabetes …

News

PCI Pharma Services to Share Expertise at Free Serialization Forum

September 9, 2016
PCI Pharma Services

Leading pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Xytnek, Antares, and Healthcare Packaging magazine, will host a …

News
Press release
afd-69766

Gilead appoints former Roche executive

September 9, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Roche, appointment

Gilead Sciences has hired Rogers Luo as vice president and general manager of commercial operations in China. Luo formerly served …

Appointment
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

Kymab demonstrates promising research for HIV vaccine development

September 9, 2016
Medical Communications, Research and Development HIV, Vaccine, kymab

Cambridge-based antibodies-to-medicines company Kymab has announced publication of research testing the first step in the effort to develop effective vaccines …

News
gsk-house-location-building

GSK proposes biopreparedness unit to combat global outbreaks

September 9, 2016
Medical Communications, Research and Development Ebola, GSK, Zika

London-based pharma giant GlaxoSmithKline has proposed the creation of a biopreparedness unit to help avert crises like those we have …

News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

September 9, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, BMS, Celgene, Cloud Computing, Eisai, FDA, GSK, Halaven, Novartis, Novo Nordisk, Roche, Teva, agios, epipen, rheumatoid arthritis

It’s Friday, and that means it’s time for another run-down of the biggest stories on Pharmafile.com over the last week. …

News

Pfizer launches legal action to block Xeljanz copies in India

September 9, 2016
Medical Communications, Sales and Marketing Pfizer, Sun Pharma, Xeljanz, Zydus Cadila, rheumatoid arthritis

Pfizer has pre-emptively sued a number of India-based drug companies including Sun Pharma and Zydus Cadila to block any attempts …

News
fda2outsideweb

FDA approves Dechra’s generic antibiotic

September 9, 2016
Medical Communications, Sales and Marketing Dechra, Putney, antiobiotic, generic

Dechra has announced that the US Food and Drug Administration (FDA) has approved its generic antibiotic. The product will be …

News

Apple introduce stricter entry requirements for health apps

September 8, 2016
Medical Communications, Research and Development Apple, Guidelines, apps, iphone, strict

Apple has toughened its stance on health and medical apps that can be bought and downloaded on the iOS App …

News
dollars_medicines

Retrophin announces positive Phase II results, Shkreli claims credit

September 8, 2016
Research and Development Phase II, Retrophin, Shkreli, rare kidney disease

Retrophin has announced positive top-line results for trial drug sparsentan in Phase II to treat a rare kidney disorder with …

News
celgene_1_02

Celgene and Agios to file FDA application for “first-in-class” cancer drug

September 8, 2016
Research and Development, Sales and Marketing Celgene, FDA, NDA, acute myeloid leukaemia, agios

According to an SEC 8-K filing by Agios, the company and its partner Celgene intend to file a new drug …

News
takeda_tokyo_hq

Takeda begins Phase III dengue vaccine trial

September 8, 2016
Research and Development Takeda, Vaccine, dengue, dengue vaccine, phase III, trial

Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …

News
c_ssilver-fotolia_ebr_jul_2014

Clinical Trial Transparency

September 8, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trial, clinical trial transparency, transparency

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …

Feature
merck_and_co

FDA to review MSD’s Keytruda as a first-line lung cancer treatment

September 7, 2016
Research and Development FDA, MSD, Merck, first-line, keytruda, lung cancer, non-small cell lung cancer, opdivo

The US Food and Drug Administration has accepted the supplemental biologics license application from MSD, known as Merck in the …

News
ole_isacson

Pfizer appoints new chief scientific officer for neuroscience research

September 7, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Ole Isacson has been named as the chief scientific officer at Pfizer’s neuroscience research unit. He will continue to …

Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026